Dr. Patricia Michele Wright, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5627 Getwell Rd, Bldg B, Ste 4, Southaven, MS 38672 Phone: 662-349-2979 Fax: 662-349-2978 |
Sarah Irby, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7075 Golden Oaks Loop W, Southaven, MS 38671 Phone: 662-228-5708 Fax: 678-868-2843 |
Olivia Chonte King Deberry Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 2103 Ansley Park Ln, Southaven, MS 38672 Phone: 901-240-2955 |
Dr. Dominik Lia Keller, PHD Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 5915 Getwell Rd Bldg B, Southaven, MS 38672 Phone: 662-349-2979 |
Dr. Shirley Ann Wilson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7165 B Swinnea, Ste 1, Southaven, MS 38671 Phone: 662-349-6658 Fax: 662-349-6856 |
Dr. Paul Sheldon Leonard, PH.D. Psychologist - Forensic Medicare: Accepting Medicare Assignments Practice Location: 7075 Golden Oaks Loop W, Southaven, MS 38671 Phone: 901-485-1848 Fax: 662-349-3988 |
News Archive
New research from an immunology team at the University of Chicago may shed light on the challenges of developing a universal flu vaccine that would provide long-lasting and broad protection against influenza viruses.
Most Canadians living with CKD have likely never spoken with their physicians about calcium and the serious health risks associated with its overuse. This is why Improving Patient Advocacy in Chronic Kidney Disease (ImPACKD), a group of CKD patients and caregivers committed to raising awareness about the risks of calcium overuse, is starting the conversation about the importance of knowing the limits and keeping them in check.
A family history of bipolar, psychotic, or substance use disorders best differentiates adolescents and young adults with emerging bipolar disorder from those with unipolar depression, say Australian researchers.
In a study examining disparities and trends in the inclusion of minorities, women, and older patients in cancer clinical trials, investigators found that certain populations remain under-represented.
The Food and Drug Administration (FDA) has approved a plastic lens that is permanently implanted into the eye to correct moderate to severe nearsightedness.
› Verified 6 days ago